Dr Gayatri Mittal

Consultant Rheumatologist

Orthopaedics

Sub-specialties: Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Hypermobility, Rheumatoid Arthritis, EDS.

Overview

bookings.orthopaedics@onewelbeck.com

02036532002

Overview

Dr Gayatri Mittal is a Consultant Rheumatologist and clinical lead for biologic and Ankylosing Spondylitis services at Royal National Orthopaedic Hospital (RNOH), Stanmore. She also holds appointment for Honorary Associate Professor at University College London, and conducts specialist clinics in spondylarthrosis, psoriatic arthritis and hypermobility at RNOH. She started practising privately in 2014.

About Dr Gayatri Mittal

Dr Gayatri Mittal is Consultant Rheumatologist and clinical lead for biologic and Ankylosing Spondylitis services at Royal National Orthopaedic Hospital (RNOH), Stanmore. She also hold appointment for Honorary Associate Professor at University College London. She conducts specialist clinics in spondylarthritis, psoriatic arthritis and hypermobility at RNOH. 


She is currently researching on designing and developing targeted intra-articular therapies for the treatment of arthritis. Her specialist training in the UK includes North East Thames Rheumatology Rotation, Clinical Research Fellowship at Bangor, North Wales and undertaking PhD at Bone and Joint Research Unit, London. She was awarded a clinical excellence award in 2016 and 2018. Prior to coming to the UK in 2002, she worked as Senior Registrar in Rheumatology at a private tertiary centre in Mumbai, India.


She is experienced in managing the whole spectrum of common and uncommon rheumatologic disorders. Her special clinical interests include inflammatory arthritis, gout and hypermobility.

Areas of Expertise

Dr Mittal treats a range of conditions, including:

She also offers the following treatments: 

  • Autoimmune serology
  • Biologics
  • DMARDs

Additional Information

Memberships: 

  • RCP
  • BSR

 

Awards: 

  • Clinical excellence awards 2016 and 2018

 

Clinical Posts: 

  • Consultant Rheumatologist, Royal National Orthopaedic Hospital and
  • Honorary Associate Professor, University College London

 

Research Highlights

  • Rapid design and implementation of a virtual pain management programme due to COVID-19: a quality improvement initiative. http://www.ncbi.nlm.nih.gov/pmc/articles/pmc8998524/
  • Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells. http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7722278/
  • Latent cytokines for targeted therapy of inflammatory disorders.. https://doi.org/10.1517/17425247.2014.863872
  • Latency can be conferred to a variety of cytokines by fusion with latency-associated peptide from TGF-β.. https://doi.org/10.1517/17425247.2013.839655
  • Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. https://doi.org/10.1093/ajcn/84.6.1463